Related Experiment Video
Updated: Jul 2, 2026
![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)
09:34
Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
Published on: February 17, 2022
Novel therapies in peripheral T-cell lymphomas
Hilary M O'Leary1, Kerry J Savage
1Department of Medical Oncology, British Columbia Cancer Agency, 600 West 10th Avenue, Vancouver, British Columbia, Canada.
Current Oncology Reports
|August 19, 2008
Summary
Peripheral T-cell lymphomas (PTCLs) have a poor prognosis with current treatments. This review explores novel targeted agents and emerging therapies aimed at improving outcomes for PTCL patients.
Area of Science:
- Oncology
- Hematology
- Immunology
Background:
- Peripheral T-cell lymphomas (PTCLs) represent a rare, heterogeneous group of hematologic malignancies.
- PTCLs are characterized by a very poor prognosis and high relapse rates following conventional chemotherapy.
- Current treatment strategies, often adapted from aggressive B-cell lymphomas, demonstrate suboptimal efficacy.
Purpose of the Study:
- To review novel targeted agents for PTCL treatment.
- To discuss emerging therapeutic approaches currently under evaluation for PTCLs.
- To highlight advancements in understanding PTCL molecular biology and pathogenesis.
Main Methods:
- Literature review of recent clinical trials and preclinical studies.
- Analysis of molecular pathways implicated in PTCL development and progression.
- Synthesis of data on novel targeted therapies and treatment strategies.
Main Results:
- Significant progress in understanding PTCL pathogenesis.
- Development of novel targeted agents showing promise in early-phase studies.
- Identification of new therapeutic strategies beyond conventional chemotherapy.
Conclusions:
- Novel targeted agents and innovative treatment approaches offer potential for improved outcomes in PTCL.
- Further research is crucial to validate these novel therapies in clinical settings.
- A deeper understanding of PTCL biology is driving the development of more effective treatments.
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...